Drs. Desai and Elbuluk review patient counseling strategies for communicating the effects of UVA radiation, the importance of sunscreen adherence, and advancements in sunscreen formulation...
PLAY
Drs. Desai and Elbuluk review patient counseling strategies for communicating the effects of UVA radiation, the importance of sunscreen adherence, and advancements in sunscreen formulation...
PLAY
Dr. Silva discusses a real-world, retrospective safety analysis¹ presented at the 2025 Revolutionizing Atopic Dermatitis Conference that showed positive safety results as well as substantial...
PLAY
Tina Bhutani, MD: Reviewing the Pathogenesis of Generalized Pustular Psoriasis
Dr. Bhutani discusses the increased level of IL-36 cytokines in patients with generalized pustular psoriasis, playing a key role in the pathogenesis of this disease...
PLAY
Andrew Mastro, MS, PA-C: Managing the Psychosocial and Occupational Burden of Chronic Hand Eczema
Andrew Mastro discusses the impact chronic hand eczema has on patients’ quality of life and provides an update on emerging treatments for the disease, such...
PLAY
Drs. Issa and Bunick dive into the possible mechanistic explanations behind arthralgia associated with dupilumab, which was detailed in a case series by Drs. Issa...
PLAY
Hadas Skupsky, MD, FAAD: Pigmented Lesion Management for the Dermatologist
Dr. Skupsky details how dermatologists can use ancillary testing to guide their decision making on atypical pigmented lesions.
PLAY
Jennifer Silva, APRN-DNP: Safety Considerations for Treating Patients with Vitiligo
Jennifer Silva discusses the importance of discussing black box warnings when utilizing JAK inhibitors in patients with vitiligo.
PLAY
Julien Seneschal, MD, PhD: An Update on Topical and Systemic JAK Inhibition for Vitiligo
Dr. Seneschal discusses currently available topical JAKs for vitiligo, systemic JAKs being trialed to treat the condition in the future, and how JAKs can be...
PLAY
Dr. Bhutani discusses how the inconvenience of frequent hospitalizations caused by GPP flare ups can diminish a patient’s quality of life.
PLAY
Andrew Mastro discusses various challenges of treating AD in the head-and-neck area, emphasizing the importance in choosing a treatment armed with rapidity, power, and a...
PLAY
Naiem T. Issa, MD, PhD: Mitigating Economic Impacts of Atopic Dermatitis through Effective Treatment
Dr. Issa discusses a real-world study¹ that demonstrated a reduced need for biologic treatments, among other AD treatments, in patients treated with topical ruxolitinib cream,...
PLAY
Jennifer Hsiao, MD: Dual Biologic Management in Hidradenitis Suppurativa
Dr. Hsiao discusses efficacy and safety of dual biologic treatment in patients with severe and recalcitrant HS, as well as commonly used biologic combinations that...
PLAY
Dr. Bhatia discusses upcoming topical therapies while honoring the utility and usefulness of older topical treatments.
PLAY
Dr. Harper discusses results from head-to-head studies comparing new and existing oral rosacea treatments and navigating the difficulties of treating neurogenic rosacea.
PLAY
Clive Maopang Liu, MD: Update on Topical Therapy for Psoriasis
Dr. Liu discusses new and emerging topical therapies for psoriasis and the continued value of topical therapies in psoriasis treatment.
PLAY
Andrea Tesvich Murina, MD: Advancements in Oral Therapies for Psoriasis
Dr. Murina discusses using oral psoriasis drugs as a stepping stone to introduce patients with psoriasis to systemic therapies.
PLAY
Mark Lebwohl, MD: Special Factors to Consider in Elderly Patients with Psoriasis
Dr. Lebwohl discusses navigating psoriasis treatment in elderly patients, including reduced renal function, increased predisposition to malignancies, and financial burdens of treatment access.
PLAY
Steven Daniel Daveluy, MD, FAAD: AI Phenotyping of Hidradenitis Suppurativa
Dr. Daveluy discusses an exciting new project to uncover insights into HS disease patterns through analysis with artificial intelligence.
PLAY
Nada Elbuluk, MD: Skin of Color Primer—Inflammatory Diseases
Dr. Elbuluk discusses unique considerations pertaining to inflammatory skin diseases in patients with skin of color.
PLAY
Dr. Khattri discusses emerging psoriatic arthritis treatments on the horizon, including deucravacitinib, zasocitinib, and icotrokinra.
PLAY
James Song, MD, FAAD: Utility of IL-17 Inhibitors for Psoriatic Disease
Dr. Song discusses the specific utility of interleukin (IL)-17 inhibitors when treating psoriatic disease, including in biologic-experienced patients, psoriasis in special sites, and psoriatic arthritis.
PLAY
Jeffrey Cohen, MD, MPH: Treatment of Psoriasis in High-impact Sites
Dr. Cohen discusses the best biologics for treating psoriasis of the scalp, intertriginous areas, genitals, nails, and palms and soles of the feet.
PLAY
Dr. Bhatia reviews exciting new developments in dermatology technology, including a full-body dermoscopic robot, autologous cell transplants for wound healing, and stem cell banking for...
PLAY
Dr. Lio discusses the nuances of approaching patient questions and misconceptions around dietary modifications and restrictions for atopic dermatitis.
PLAY
Emmy Graber, MD: New Efficacy Evidence for Acne and Rosacea Devices
Dr. Graber discusses new evidence supporting the use of 1726nm lasers for the treatment of inflammatory and non-inflammatory acne, as well as pulsed-dye laser and...
PLAY
Steve Daveluy, MD: Using Cryoinsufflation in Patients with Hidradenitis Suppurativa
Dr. Daveluy provides tips and guidance for using cryoinsufflation in the treatment of HS.
PLAY
Christopher Bunick, MD, PhD: Clearing Up Questions Around Benzene in Benzoyl Peroxide Products
Dr. Bunick explores the discussion on benzene in benzoyl peroxide (BPO) products, including questions around ensuring products are meeting FDA regulations, what dermatologists can do...
PLAY
Jennifer Hsiao, MD: Recalcitrant Hidradenitis Suppurativa—What to do Next?
Dr. Jennifer Hsiao shares emerging strategies for treating recalcitrant hidradenitis suppurativa when standard therapies fail. Topics Covered: Management of treatment-resistant HS Emerging therapies and clinical...
PLAY
Christopher Bunick, MD, PhD: Antibiotic Update for Acne and Rosacea
Dr. Bunick provides a comprehensive update on using antibiotics for the treatment of acne and rosacea, including influences on gut health, antibiotic resistance, and efficacy...
PLAY
Lisa Swanson, MD: What’s New in Pediatric Dermatology at AAD 2025
Dr. Swanson discusses the most exciting developments across pediatric atopic dermatitis, psoriasis, alopecia areata, vitiligo, and infantile hemangiomas.
PLAY
Dr. Lio discusses several alternative approaches to managing itch in patients who are being treated for non-dermatologic cancers.
PLAY
Steve Daveluy, MD: Pharm to Table: How Medications and Diet Interact
Dr. Daveluy reviews how diet can influence the effectiveness and side effects of certain dermatological drugs.
PLAY
Dr. Chovatiya discusses a symposium that he participated in at AAD 2025 focused on chronic hand eczema, reviewing prevalence, subtypes, morphology, and other important considerations...
PLAY
David Rosmarin, MD: How to Use Ruxolitinib Cream for Vitiligo
Dr. Rosmarin highlights his presentation from AAD 2025, in which he reviewed the optimal method for using ruxolitinib cream for vitiligo, touching on setting patient...
PLAY
Dr. Hamzavi reviews the correct patient candidate for surgical therapy for vitiligo and the different options available, including punch grafting, suction blister epidermal grafting, and...
PLAY
Iltefat Hamzavi, MD: Carbon Dioxide Laser for Hidradenitis Suppurativa
Dr. Hamzavi discusses key points from his presentation within the AAD 2025 session on surgical options for hidradenitis suppurativa.
PLAY
Aaron Drucker MD, SCM, FRCPC: A Network Meta-analysis of Systemic Therapies for Atopic Dermatitis
In a summary of one of his talks from AAD 2025, Dr. Drucker discusses the results from a network meta-analysis that provides insight beyond the...
PLAY
Dr. Chovatiya reviews one of his AAD sessions in which he discussed atopic dermatitis, hidradenitis suppurativa, and psoriasis in patients with skin of color. In...
PLAY
Melinda Gooderham, MSc, MD, FRCPC: JAK Inhibitors for Psoriasis
Dr. Gooderham discusses JAK inhibition in the context of psoriasis treatment, including comparing the important difference between competitive inhibition and allosteric inhibition when using JAKs...
PLAY
In an overview from his AAD 2025 presentation, Dr. Seneschal reviews important dimensions of the pathogenesis of vitiligo that necessitate maintenance therapy.
PLAY
Here, Dr. Draelos summarizes the patient-reported outcomes of a recently published study in the March 2025 issue of JCAD,¹ reviewing results from the subject self-assessment...
PLAY
Dr. Valacchi reviews histological findings from a study published in the March 2025 issue of JCAD,¹ which investigated a dietary supplement’s effect on biomarkers of...
PLAY
Dr. Draelos discusses methods and findings of a study published in the March 2025 issue of JCAD,¹ which evaluated the safety and efficacy of a...
PLAY
Episode 3—Zoe Draelos, MD, and Giuseppe Valacchi, PhD: The Role of Plant Extracts on Skin Glycation
The third video in The Science of Skin Glycation series features Drs. Zoe Draelos and Giuseppe Valacchi, who discuss research on the potential of rosemary...
PLAY
In the second video in The Science of Skin Glycation series, Drs. Bucay and Watchmaker discuss the potential of oral flavonoids, with a special focus...
PLAY
In the first of a six-video series exploring glycative stress on the skin, Drs. Jacqueline Watchmaker and Vivian Bucay review the effects of glycation on...
PLAY
Dr. Marghoob discusses how the microanatomy of the face, palms, and nails impacts diagnosing melanomas.
PLAY
James Song, MD: New Topical and Systemic Agents for Atopic Dermatitis
Dr. Song provides an extensive overview of what’s new and emerging in atopic dermatitis treatment. Listen to Dr. Song’s full recap on our JCAD Podcast...
PLAY
Dr. Jenny Murase reviews a decade of insights on safety considerations for dermatologic treatments for pregnant and lactating patients. Topics Covered: Safe dermatologic treatments during...
PLAY
Jenny Murase, MD: Safe Medical Management of Skin Disease in Pregnancy
Dr. Murase reviews a decade of insights on safety considerations for dermatologic treatments for pregnant and lactating patients.
PLAY
Jennifer Hsiao, MD: Discussions in Chronic Spontaneous Urticaria
Dr. Hsiao discusses alternate long-term therapeutic options for patients with CSU.
PLAY
Dr. High discusses two immunostains, p16 and PRAME, as well as gene expression profiling, as helpful tools for identifying melanoma.
PLAY
Prithwiraj Maitra, PhD: Biomarker Evaluation in Skincare Research
Dr. Maitra reviews his session presented at the Science of Skincare Summit 2024.
PLAY
Dr. Lain reviews his session presented at the Science of Skincare Summit 2024.
PLAY
Dr. Frey reviews her session presented at the Science of Skincare Summit 2024.
PLAY
Monica Richey, NP: Future Roles of APPS in Rheumatology and Dermatology
Monica discusses the future of APPs in the rheumatology space and how these clinicians may fill a shortage of rheumatologists in rural areas in the...
PLAY
David Rosmarin, MD: Itch in 2024: Urticaria, Prurigo Nodularis and Beyond
Dr. Rosmarin reviews his process for evaluating itch in a patient and matching patients with different types of itch to the most effective treatment.
PLAY
David Rosmarin, MD: Atopic Dermatitis at Masterclasses in Dermatology
Dr. David Rosmarin shares expert hygiene strategies and treatment tips for managing atopic dermatitis, presented at the 2024 Masterclasses in Dermatology. Topics Covered: Patient hygiene...
PLAY
Donna Culton, MD, PhD: Atypical Presentations of Blistering Diseases
Dr. Culton discusses diagnosing non-blistering clinical phenotypes of pemphigoid and pemphigus and the increasingly common prevalence of drug-induced pemphigoid.
PLAY
Dr. Zirwas discusses clinical impacts of notable additions to the dermatology literature this year—including 1% diclofenac gel for acne keloidalis nuchae and pseudofolliculitis barbae and...
PLAY
Dr. Marghoob discusses dysplastic nevi as markers of increased risk for melanoma, then elaborates on optimal approaches to detection, screening, monitoring, and biopsy of these...
PLAY
Julie Harper, MD: Treating Disrupted Skin Barriers in Patients with Acne
Dr. Harper discusses repairing and maintaining the skin barrier in her patients with acne by first discontinuing the use of topical products and medications that...
PLAY
Dr. Arbiser reviews the signaling mechanisms of ceramides in barrier-disrupted skin.
PLAY
Andrew Alexis, MD, MPH: The Role of Ceramides in Patients with Acne
Dr. Alexis discusses the reduction in total ceramide content in the skin of patients with moderate acne and how this issue can be addressed through...
PLAY
Watch this three-module series with James Del Rosso, DO, who discusses the benefits of semi-occlusive healing ointments over occlusive ointments and petrolatum and their impact on the skin healing process.
Dr. Strober focuses on difficult-to-treat areas in patients with psoriasis and the tremendous impact on quality of life this disease can have.